←Back to structures
OQ709200.1__WGH20064.1__X__00029
Bact-VirOQ709200.1__WGH20064.1__X__00029
Identity
- Accession:
- OQ709200 ↗
- Kingdom:
- phage
Quality
71.7
mean pLDDT
Taxonomy
TaxID: 3038367
Cluster
View cluster (4 members)3D Structure
Domains
high = three domain segmentations agree, medium = two domain segmentations agree. Numbered high-first then medium, N→C within each tier.
D1
high
residues 36-122
Domain cluster:
rep: MZ923504.1__UIU47042.1__X__00028__D27-103
CATH (69)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3n8bA00 | 3.10.450.700 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.86 | 51.0 | 5.48e-01 | 71.3% | 69.3% |
| 3cnxA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.75 | 69.0 | 5.86e-01 | 100.0% | 95.7% |
| 3soyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.75 | 68.0 | 5.76e-01 | 100.0% | 90.8% |
| 3a76A01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.75 | 69.0 | 5.82e-01 | 100.0% | 90.6% |
| 3ejvA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.75 | 67.0 | 5.52e-01 | 100.0% | 94.3% |
| 3robA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.74 | 68.0 | 5.87e-01 | 100.0% | 93.9% |
| 4o3vA00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.74 | 67.0 | 5.75e-01 | 100.0% | 94.2% |
| 3d9rB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 66.0 | 5.73e-01 | 100.0% | 94.0% |
| 3bb9B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 65.0 | 5.71e-01 | 96.6% | 96.0% |
| 4jf8A00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.73 | 66.0 | 5.56e-01 | 100.0% | 93.8% |
| 4gb5A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 66.0 | 5.50e-01 | 100.0% | 90.5% |
| 5ig0A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 66.0 | 5.74e-01 | 100.0% | 96.9% |
| 4ccvA00 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 64.0 | 5.85e-01 | 97.7% | 80.0% |
| 2rgqB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 65.0 | 5.59e-01 | 100.0% | 91.0% |
| 3gwrB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 63.0 | 5.54e-01 | 96.6% | 94.5% |
| 3kspA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 65.0 | 5.67e-01 | 100.0% | 93.0% |
| 1q42A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 65.0 | 5.29e-01 | 100.0% | 95.6% |
| 2rfrA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 64.0 | 5.30e-01 | 100.0% | 81.8% |
| 3ef8A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 64.0 | 5.37e-01 | 100.0% | 84.5% |
| 2b1xB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 63.0 | 5.11e-01 | 100.0% | 89.2% |
| 2chcC00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 63.0 | 5.17e-01 | 100.0% | 76.1% |
| 3gzrB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 64.0 | 5.39e-01 | 100.0% | 90.8% |
| 3f7sA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 63.0 | 5.35e-01 | 100.0% | 86.6% |
| 3e99A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 62.0 | 5.24e-01 | 100.0% | 91.9% |
| 3ebyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 62.0 | 5.15e-01 | 100.0% | 88.9% |
| 1q40D00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 63.0 | 4.97e-01 | 100.0% | 94.3% |
| 4lgqA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 63.0 | 5.43e-01 | 100.0% | 95.5% |
| 3dmcA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 62.0 | 5.36e-01 | 100.0% | 94.0% |
| 3fsdA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 62.0 | 5.53e-01 | 98.9% | 98.3% |
| 3f7xA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 62.0 | 5.38e-01 | 100.0% | 95.5% |
| 3hx8A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 61.0 | 5.40e-01 | 100.0% | 96.9% |
| 5cxoB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 62.0 | 5.31e-01 | 100.0% | 90.3% |
| 2w4yA00 | 2.40.160.220 | Mainly Beta › Beta Barrel › Porin › | 0.68 | 46.0 | 4.05e-01 | 70.1% | 49.2% |
| 3grdA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 61.0 | 5.32e-01 | 100.0% | 93.9% |
| 1uliB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 60.0 | 4.78e-01 | 100.0% | 86.4% |
| 2r4iA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.67 | 61.0 | 5.38e-01 | 100.0% | 96.7% |
| 3ff0A01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.67 | 60.0 | 5.11e-01 | 100.0% | 89.4% |
| 3ff2A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 58.0 | 5.31e-01 | 98.9% | 99.1% |
| 3rgaA01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 58.0 | 5.09e-01 | 100.0% | 91.7% |
| 3ehcB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 58.0 | 5.13e-01 | 100.0% | 92.2% |
| 3lh4A00 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 57.0 | 5.22e-01 | 98.9% | 85.2% |
| 1pfoA02 | 3.30.1040.20 | Alpha Beta › 2-Layer Sandwich › Carboxypeptidase Inhibitor; Chain A › | 0.65 | 34.0 | 4.36e-01 | 100.0% | 86.8% |
| 3er7B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.64 | 55.0 | 4.94e-01 | 96.6% | 95.9% |
| 2bi0A01 | 3.10.129.10 | Alpha Beta › Roll › Thiol Ester Dehydrase; Chain A › Hotdog Thioesterase | 0.63 | 47.0 | 3.89e-01 | 79.3% | 96.1% |
| 2k54A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.62 | 57.0 | 5.05e-01 | 100.0% | 92.7% |
| 3icyA00 | 3.30.450.20 | Alpha Beta › 2-Layer Sandwich › Beta-Lactamase › PAS domain | 0.62 | 48.0 | 4.33e-01 | 81.6% | 68.6% |
| 1ewfA02 | 3.15.20.10 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 2 › Bactericidal permeability-increasing protein; domain 2 | 0.62 | 54.0 | 3.86e-01 | 100.0% | 58.3% |
| 4ge1C00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.61 | 55.0 | 4.23e-01 | 98.9% | 59.1% |
| 2r5rA00 | 3.10.270.10 | Alpha Beta › Roll › Urate Oxidase › Urate Oxidase; | 0.61 | 50.0 | 3.57e-01 | 88.5% | 45.5% |
| 2gtlO02 | 2.40.128.620 | Mainly Beta › Beta Barrel › Lipocalin › | 0.61 | 53.0 | 4.34e-01 | 100.0% | 52.1% |
| 3e8tA00 | 3.15.10.30 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › TULIP domain | 0.61 | 54.0 | 4.07e-01 | 100.0% | 67.6% |
| 2obdA01 | 3.15.20.10 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 2 › Bactericidal permeability-increasing protein; domain 2 | 0.60 | 54.0 | 3.75e-01 | 98.9% | 44.9% |
| 4e1sA00 | 2.40.160.160 | Mainly Beta › Beta Barrel › Porin › Inverse autotransporter, beta-domain | 0.59 | 52.0 | 3.77e-01 | 96.6% | 75.2% |
| 1pp0B00 | 3.40.198.10 | Alpha Beta › 3-Layer(aba) Sandwich › Delta-endotoxin CytB › Delta-endotoxin CytB-like | 0.59 | 49.0 | 3.82e-01 | 92.0% | 58.2% |
| 1olzA01 | 2.130.10.10 | Mainly Beta › 7 Propeller › Methylamine Dehydrogenase; Chain H › YVTN repeat-like/Quinoprotein amine dehydrogenase | 0.58 | 53.0 | 3.29e-01 | 100.0% | 22.1% |
| 2gtlM02 | 2.40.128.620 | Mainly Beta › Beta Barrel › Lipocalin › | 0.58 | 52.0 | 4.20e-01 | 100.0% | 52.4% |
| 3nvqA01 | 2.130.10.10 | Mainly Beta › 7 Propeller › Methylamine Dehydrogenase; Chain H › YVTN repeat-like/Quinoprotein amine dehydrogenase | 0.57 | 52.0 | 3.29e-01 | 100.0% | 23.5% |
| 3aa0B02 | 3.90.1150.210 | Alpha Beta › Alpha-Beta Complex › Aspartate Aminotransferase, domain 1 › F-actin capping protein, beta subunit | 0.56 | 50.0 | 4.16e-01 | 100.0% | 86.5% |
| 3v89A02 | 2.40.170.20 | Mainly Beta › Beta Barrel › Maltoporin; Chain A › TonB-dependent receptor, beta-barrel domain | 0.56 | 45.0 | 2.72e-01 | 87.4% | 91.3% |
| 3pgbA01 | 2.70.98.20 | Mainly Beta › Distorted Sandwich › Beta-galactosidase; Chain A, domain 5 › Copper amine oxidase, catalytic domain | 0.55 | 47.0 | 2.89e-01 | 100.0% | 15.9% |
| 6lofA00 | 2.40.155.10 | Mainly Beta › Beta Barrel › Green Fluorescent Protein › Green fluorescent protein | 0.55 | 43.0 | 3.50e-01 | 83.9% | 97.5% |
| 3c7fA02 | 2.115.10.20 | Mainly Beta › 5 Propeller › Tachylectin-2; Chain A › Glycosyl hydrolase domain; family 43 | 0.53 | 46.0 | 3.14e-01 | 98.9% | 31.6% |
| 7a0hA02 | 3.90.1150.210 | Alpha Beta › Alpha-Beta Complex › Aspartate Aminotransferase, domain 1 › F-actin capping protein, beta subunit | 0.53 | 47.0 | 3.78e-01 | 98.9% | 84.5% |
| 6f1uK02 | 3.90.1150.210 | Alpha Beta › Alpha-Beta Complex › Aspartate Aminotransferase, domain 1 › F-actin capping protein, beta subunit | 0.52 | 46.0 | 3.93e-01 | 100.0% | 86.2% |
| 3bf2A00 | 3.30.160.150 | Alpha Beta › 2-Layer Sandwich › Double Stranded RNA Binding Domain › Lipoprotein like domain | 0.52 | 42.0 | 3.83e-01 | 93.1% | 88.8% |
| 3pqvA02 | 3.30.360.20 | Alpha Beta › 2-Layer Sandwich › Dihydrodipicolinate Reductase; domain 2 › RNA 3'-terminal phosphate cyclase, insert domain | 0.51 | 43.0 | 4.17e-01 | 100.0% | 84.4% |
| 3bvxA05 | 2.60.40.1360 | Mainly Beta › Sandwich › Immunoglobulin-like › | 0.51 | 35.0 | 3.44e-01 | 71.3% | 100.0% |
| 1l3aA00 | 2.30.31.10 | Mainly Beta › Roll › Transcriptional Co-activator pc4; Chain A › Transcriptional Coactivator Pc4; Chain A | 0.51 | 39.0 | 3.18e-01 | 82.8% | 80.7% |
| 2n8xA00 | 3.30.160.150 | Alpha Beta › 2-Layer Sandwich › Double Stranded RNA Binding Domain › Lipoprotein like domain | 0.50 | 41.0 | 3.41e-01 | 93.1% | 69.3% |
ECOD (87)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3961892 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.78 | 71.0 | 6.05e-01 | 100.0% | 92.1% |
| 3941713 | 243.1.1.6 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › VirB8 | 0.78 | 70.0 | 5.95e-01 | 98.9% | 99.3% |
| 5002369 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.78 | 69.0 | 6.26e-01 | 96.6% | 96.5% |
| 3278632 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.78 | 71.0 | 6.07e-01 | 100.0% | 92.6% |
| 3281242 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.75 | 68.0 | 5.96e-01 | 100.0% | 94.6% |
| 3974899 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.75 | 68.0 | 5.73e-01 | 100.0% | 89.0% |
| 3689197 | 3863.1.1.1 ↗ | beta barrels › Virulence associated protein B (Vapb) › Virulence associated protein B (Vapb) › Virulence associated protein B (Vapb) › Ysc84 | 0.75 | 54.0 | 4.17e-01 | 74.7% | 68.9% |
| 5022156 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.75 | 68.0 | 5.79e-01 | 100.0% | 90.6% |
| 3286818 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.75 | 63.0 | 5.52e-01 | 92.0% | 100.0% |
| 3283278 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.74 | 68.0 | 5.83e-01 | 100.0% | 95.6% |
| 143237 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.74 | 68.0 | 5.87e-01 | 100.0% | 93.9% |
| 1674783 | 243.1.1.15 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › T4BSS_DotI_IcmL | 0.74 | 68.0 | 5.75e-01 | 100.0% | 93.5% |
| 3290450 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.74 | 67.0 | 5.64e-01 | 100.0% | 88.8% |
| 3957821 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.74 | 67.0 | 5.84e-01 | 100.0% | 97.7% |
| 3355665 | 3863.1.1.1 ↗ | beta barrels › Virulence associated protein B (Vapb) › Virulence associated protein B (Vapb) › Virulence associated protein B (Vapb) › Ysc84 | 0.74 | 53.0 | 3.95e-01 | 74.7% | 62.9% |
| 3438167 | 3863.1.1.1 ↗ | beta barrels › Virulence associated protein B (Vapb) › Virulence associated protein B (Vapb) › Virulence associated protein B (Vapb) › Ysc84 | 0.74 | 53.0 | 4.10e-01 | 74.7% | 71.7% |
| 3962739 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.73 | 67.0 | 5.53e-01 | 100.0% | 82.0% |
| 6405 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.73 | 66.0 | 5.73e-01 | 100.0% | 96.2% |
| 3962486 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.73 | 66.0 | 5.45e-01 | 100.0% | 80.5% |
| 3967916 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.72 | 66.0 | 5.48e-01 | 100.0% | 84.5% |
| 4950139 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.72 | 65.0 | 5.78e-01 | 100.0% | 98.4% |
| 3291354 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.72 | 66.0 | 5.06e-01 | 100.0% | 63.7% |
| 3953277 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.72 | 65.0 | 5.49e-01 | 100.0% | 88.3% |
| 3960457 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.72 | 65.0 | 5.37e-01 | 100.0% | 82.6% |
| 3698353 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.72 | 65.0 | 5.76e-01 | 100.0% | 99.2% |
| 3394181 | 206.1.1.55 ↗ | a+b complex topology › Protein kinase/SAICAR synthase/ATP-grasp › Protein kinase/SAICAR synthase/ATP-grasp › Protein kinase › EcKL | 0.72 | 64.0 | 4.08e-01 | 97.7% | 32.3% |
| 2632043 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.72 | 64.0 | 5.49e-01 | 100.0% | 90.7% |
| 3960625 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.72 | 64.0 | 5.37e-01 | 100.0% | 90.7% |
| 5003871 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.72 | 65.0 | 5.53e-01 | 100.0% | 94.3% |
| 3281901 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.72 | 63.0 | 5.33e-01 | 97.7% | 88.3% |
| 4927181 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.71 | 64.0 | 5.62e-01 | 100.0% | 95.3% |
| 3977502 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.71 | 65.0 | 5.63e-01 | 100.0% | 90.8% |
| 3960172 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.71 | 58.0 | 5.21e-01 | 87.4% | 91.5% |
| 3588483 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.71 | 64.0 | 5.52e-01 | 100.0% | 93.3% |
| 3718679 | 4252.1.1.10 ↗ | beta barrels › AttH-like › AttH-like › AttH-like › DUF2804 | 0.70 | 63.0 | 4.65e-01 | 100.0% | 76.5% |
| 3870424 | 3863.1.1.1 ↗ | beta barrels › Virulence associated protein B (Vapb) › Virulence associated protein B (Vapb) › Virulence associated protein B (Vapb) › Ysc84 | 0.70 | 50.0 | 3.69e-01 | 74.7% | 56.4% |
| 5059048 | 243.1.1.13 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › CaMKII_AD | 0.70 | 64.0 | 5.66e-01 | 100.0% | 98.4% |
| 3925421 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.70 | 62.0 | 5.89e-01 | 96.6% | 88.0% |
| 3940802 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.70 | 63.0 | 5.90e-01 | 100.0% | 87.6% |
| 3934735 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.69 | 62.0 | 5.89e-01 | 96.6% | 88.0% |
| 3937044 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.69 | 63.0 | 6.12e-01 | 98.9% | 98.9% |
| 3971296 | 243.1.1.5 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Tim44 | 0.69 | 62.0 | 5.44e-01 | 100.0% | 93.0% |
| 3285746 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.69 | 62.0 | 5.09e-01 | 100.0% | 80.0% |
| 3725114 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.69 | 61.0 | 5.17e-01 | 100.0% | 87.6% |
| 3714422 | 4252.1.1.0 ↗ | beta barrels › AttH-like › AttH-like › AttH-like | 0.68 | 61.0 | 4.48e-01 | 100.0% | 74.9% |
| 3959285 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.68 | 54.0 | 5.57e-01 | 85.1% | 96.4% |
| 3281948 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.68 | 59.0 | 5.26e-01 | 94.3% | 97.5% |
| 4884000 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.68 | 58.0 | 4.74e-01 | 93.1% | 91.0% |
| 3811744 | 243.1.1.49 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF2358 | 0.68 | 62.0 | 5.24e-01 | 100.0% | 85.0% |
| 1562283 | 243.1.1.11 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › LEH | 0.68 | 61.0 | 5.32e-01 | 98.9% | 88.4% |
| 3242736 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.67 | 61.0 | 5.18e-01 | 100.0% | 88.6% |
| 3511571 | 883.1.1.2 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP_C | 0.67 | 61.0 | 4.30e-01 | 100.0% | 50.2% |
| 4020985 | 3863.1.1.0 ↗ | beta barrels › Virulence associated protein B (Vapb) › Virulence associated protein B (Vapb) › Virulence associated protein B (Vapb) | 0.67 | 48.0 | 4.04e-01 | 74.7% | 71.7% |
| 3188192 | 3863.1.1.1 ↗ | beta barrels › Virulence associated protein B (Vapb) › Virulence associated protein B (Vapb) › Virulence associated protein B (Vapb) › Ysc84 | 0.67 | 48.0 | 4.03e-01 | 74.7% | 71.7% |
| 3926039 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.67 | 60.0 | 5.78e-01 | 100.0% | 90.0% |
| 3515333 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.66 | 60.0 | 5.95e-01 | 98.9% | 97.8% |
| 3731226 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.66 | 59.0 | 4.94e-01 | 100.0% | 84.0% |
| 3430917 | 881.1.1.2 ↗ | a+b three layers › Mog1p/PsbP-like › Mog1p/PsbP-like › Mog1p/PsbP-like › Mog1 | 0.66 | 60.0 | 4.55e-01 | 100.0% | 45.0% |
| 3663259 | 881.1.1.1 ↗ | a+b three layers › Mog1p/PsbP-like › Mog1p/PsbP-like › Mog1p/PsbP-like › PsbP | 0.64 | 54.0 | 4.66e-01 | 100.0% | 59.3% |
| 5038486 | 881.1.1.0 ↗ | a+b three layers › Mog1p/PsbP-like › Mog1p/PsbP-like › Mog1p/PsbP-like | 0.64 | 56.0 | 4.31e-01 | 100.0% | 42.5% |
| 3462995 | 708.1.1.1 ↗ | beta complex topology › ETN0001 domain-like › ETN0001 domain-like › NAC/WRKY/GCM/WOPR domain › NAM | 0.64 | 48.0 | 3.95e-01 | 82.8% | 72.9% |
| 3270456 | 331.3.1.17 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › VASt | 0.63 | 55.0 | 4.17e-01 | 100.0% | 42.1% |
| 3829111 | 881.1.1.1 ↗ | a+b three layers › Mog1p/PsbP-like › Mog1p/PsbP-like › Mog1p/PsbP-like › PsbP | 0.62 | 56.0 | 4.23e-01 | 100.0% | 42.9% |
| 3706524 | 5.1.2.33 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 5-bladed › BNR_3 | 0.62 | 55.0 | 3.83e-01 | 100.0% | 40.0% |
| 3281675 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.62 | 51.0 | 4.86e-01 | 90.8% | 85.7% |
| 4029724 | 883.1.1.6 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1_N | 0.61 | 54.0 | 4.56e-01 | 100.0% | 65.1% |
| 3701306 | 331.3.1.17 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › VASt | 0.61 | 56.0 | 4.14e-01 | 100.0% | 41.9% |
| 3764436 | 883.1.1.1 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP | 0.61 | 53.0 | 4.30e-01 | 100.0% | 62.9% |
| 3940862 | 883.1.1.15 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP+LBP_BPI_CETP_C | 0.61 | 55.0 | 3.46e-01 | 100.0% | 28.9% |
| 3593049 | 331.3.1.0 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like | 0.60 | 56.0 | 4.14e-01 | 100.0% | 41.9% |
| 3622962 | 331.3.1.17 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › VASt | 0.60 | 54.0 | 3.85e-01 | 98.9% | 38.0% |
| 4647627 | 883.1.1.1 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP | 0.60 | 52.0 | 4.00e-01 | 100.0% | 59.1% |
| 3237501 | 883.1.1.0 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like | 0.60 | 53.0 | 3.51e-01 | 100.0% | 31.1% |
| 3653384 | 708.1.1.1 ↗ | beta complex topology › ETN0001 domain-like › ETN0001 domain-like › NAC/WRKY/GCM/WOPR domain › NAM | 0.59 | 45.0 | 3.83e-01 | 85.1% | 67.7% |
| 3569021 | 883.1.1.1 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP | 0.58 | 51.0 | 3.99e-01 | 97.7% | 64.3% |
| 3929593 | 883.1.1.2 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP_C | 0.58 | 49.0 | 3.64e-01 | 100.0% | 52.7% |
| 3207721 | 2008.1.1.0 ↗ | a/b three-layered sandwiches › Restriction endonuclease-like › Restriction endonuclease-like › Restriction endonuclease-like | 0.57 | 47.0 | 3.58e-01 | 92.0% | 85.6% |
| 4296505 | 5084.5.1.52 ↗ | beta barrels › Outer membrane meander beta-barrels › Porins › Porin › SlpA_C | 0.57 | 50.0 | 3.35e-01 | 97.7% | 28.2% |
| 3300968 | 5.1.4.0 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 7-bladed | 0.56 | 49.0 | 2.90e-01 | 100.0% | 22.7% |
| 4028624 | 5084.5.1.3 ↗ | beta barrels › Outer membrane meander beta-barrels › Porins › Porin › Porin_3 | 0.55 | 49.0 | 3.43e-01 | 98.9% | 77.2% |
| 5065294 | 4051.1.1.0 ↗ | a+b two layers › a+b domain in Capz › a+b domain in Capz › a+b domain in Capz | 0.55 | 48.0 | 3.96e-01 | 100.0% | 77.6% |
| 3593966 | 1116.1.1.0 ↗ | a+b two layers › Polycystin-mucolipin domain › Polycystin-mucolipin domain › Polycystin-mucolipin domain | 0.55 | 48.0 | 3.69e-01 | 100.0% | 81.0% |
| 4025435 | 4051.1.1.2 ↗ | a+b two layers › a+b domain in Capz › a+b domain in Capz › a+b domain in Capz › F-actin_cap_A | 0.55 | 49.0 | 3.84e-01 | 100.0% | 79.5% |
| 3406725 | 5087.2.1.2 ↗ | beta meanders › Lipovitellin-phosvitin complex › Lipovitellin LV-1N › Lipovitellin LV-1N › PF29934 | 0.53 | 45.0 | 3.25e-01 | 96.6% | 41.5% |
| 4946087 | 283.2.1.0 ↗ | a+b duplicates or obligate multimers › Creatinase/aminopeptidase-like › gpW/gp25-like › gpW/gp25-like | 0.52 | 46.0 | 4.12e-01 | 98.9% | 78.4% |
| 4959666 | 331.4.1.0 ↗ | a+b two layers › TBP-like › Kinase associated domain 1, KA1 › Kinase associated domain 1, KA1 | 0.51 | 45.0 | 3.79e-01 | 100.0% | 75.5% |
| 3285272 | 868.1.1.1 ↗ | a+b complex topology › mRNA triphosphatase CET1-related › mRNA triphosphatase CET1-related › mRNA triphosphatase CET1-related › CYTH | 0.50 | 42.0 | 3.27e-01 | 92.0% | 92.3% |